Powered by HumanexaHumanexa Review

Editorial intelligence for pharma strategy

AnalysisResearchOpinionCalendarNewsletterAbout
Pharma StrategyDrug DevelopmentCompetitive IntelligenceAI & HealthcareBiotech BusinessIndustry Analysis

Humanexa Review

Independent editorial analysis on pharma strategy, drug development, and market structure in life sciences.

Powered by Humanexa

AboutStudioNewsletterCalendar
Explore Humanexa Intelligence Platform

Publication calendar

When we publish

Browse Humanexa Review articles by publication date. Select a highlighted day to read what we published.

June 2026

Mon
Tue
Wed
Thu
Fri
Sat
Sun

Selected day

Monday, June 22, 2026

Biotech Business·6 min read

In-Licensing Economics in a Higher-Cost-of-Capital Cycle

Rising cost of capital is compressing in-licensing valuations and shifting deal structures toward milestones, royalties, and staged proof points.

Humanexa Research